Cargando…
DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy
This study is to investigate multiple chemotherapeutic agent- and radiation-related genetic biomarkers in locally advanced rectal cancer (LARC) patients following fluoropyrimidine-based concurrent chemoradiotherapy (CCRT) for response prediction. We initially selected 6 fluoropyrimidine metabolism-r...
Autores principales: | Huang, Ming-Yii, Wu, Chan-Han, Huang, Chun-Ming, Chung, Fu-Yen, Huang, Ching-Wen, Tsai, Hsiang-Lin, Chen, Chin-Fan, Lin, Shiu-Ru, Wang, Jaw-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3884968/ https://www.ncbi.nlm.nih.gov/pubmed/24455740 http://dx.doi.org/10.1155/2013/931028 |
Ejemplares similares
-
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity
por: Loganayagam, A, et al.
Publicado: (2013) -
Pharmacogenetic Variants in the DPYD and TYMS Genes are Clinically Significant Predictors of Fluoropyrimidine Toxicity: Are We Ready for Use in our Clinical Practice
por: Saif, Muhammad Wasif, et al.
Publicado: (2020) -
Effective Tcl/Tk programming: writing better programs with Tcl and Tk
por: Harrison, Mark, et al.
Publicado: (1998) -
Tcl and the Tk toolkit /
por: Ousterhout, John K.
Publicado: (1994) -
Tcl and the Tk toolkit
por: Ousterhout, John K
Publicado: (1994)